Global Injection Pen Market Analysis
Injection pens have traditionally been employed for self-administering conserved multi-dose medication compositions that require weight-based dosage on a regular basis. There are two types of injectable pens: reusable and disposable. Injection pens are suitable to use as a prefilled medical device that makes it easier for patients, caregivers, and healthcare providers to administer drugs or biostimulants. In contrast to the incidence of chronic diseases, recent advancements in injectable pen devices such as the use of needle safety devices, automated needle insertion and injection, smaller dosage capabilities, and electronics are projected to boost the global injection pen market. In addition, simple reimbursement and more FDA approval would enhance the injectable pen market, but preference for alternate drug delivery modalities and bad reimbursement scenarios in emerging nations may stymie expansion of the global injection pen market.
Enhancing the comfort and simplicity of administration of parenteral treatments has become a typical technique followed by the biotechnology and pharmaceutical sectors, and it is projected to propel the global injection pen market forward. To meet shifting injection pen market trends, key companies strive to develop innovative drug delivery systems that target end-user flexibility such as fewer handling steps, larger volumes, thinner needles, high viscosity formulations, and novel main containers.
Antares Pharma and AMAG Pharmaceuticals collaborated to produce Makena subcutaneous auto injector in 2015. This partnership combines Antares Pharma’s hydroxyprogesterone caproate injection, which is used to mitigate the risk of preterm birth in women who are pregnant with a single baby and have a history of singleton spontaneous preterm birth, with AMAG Pharmaceuticals’ QuickShot auto-injector, which allows rapid subcutaneous self-administration of highly viscous drugs in oil such as testosterone or progesterone.
Chronic illnesses are becoming more common as the population ages, and individuals with chronic disorders including diabetes, multiple sclerosis (MS), rheumatoid arthritis (RA), hepatitis, osteoporosis, hemophilia, reproductive health, anemia, hemolytic disease, and anti-thrombolytic treatment live longer. Due to the prevalence of disease, the injection pen market has dominated diabetes and growth hormone therapy for the past 20 years and ten years, respectively. As per the American Diabetes Association, 9.4 percent of Americans had diabetes in 2015, and 1.5 million people were diagnosed with the disease each year. This points to the injectable pen market’s dominance in the diabetes therapy. Furthermore, recent developments have expanded the range of injectable pen applications to include reproductive health, osteoporosis, and hepatitis.
In addition, injection pen manufacturers are concentrating on device innovations or the corporate pipeline to satisfy the demands of next-generation molecules and expected end-user needs. In 2015, Biocorp released two internet-connected gadgets, Datapen and Easylog. Dose setup, OLED display, audio and visual signals to help patients, and real-time transfer of treatment information to the storage platform and mobile app are some of the other characteristics of the Datapen and Easylog devices. Increased pipeline product will result in more treatment alternatives for medical practitioners and patients, driving the global injection pen market forward.
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2050
Due to the rising product advancements by major companies in the region, North America holds a dominant position in the global injection pen market, whereas Asia Pacific is anticipated to be the quick-rising market during the forecast period given the growing population combined with the advancement of healthcare facilities.
Major companies contributing in the global injection pen market are AstraZeneca PLC, Novo Nordisk, Biocorp Production SA, Dickinson and Company (BD), Novartis, Merck & co., Inc., ELI Lilly and Company, Wilhelm Haselmeier GmbH & Co. KG., Ypsomed holding AG, Pfizer, Owen Mumford Ltd, Becton, Sanofi, and F.Hoffman-La Roche Ltd.
Main points in Injection Pen Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Injection Pen Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Injection Pen Industry Impact
Chapter 2 Global Injection Pen Competition by Types, Applications, and Top Regions and Countries
2.1 Global Injection Pen (Volume and Value) by Type
2.3 Global Injection Pen (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Injection Pen Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Injection Pen Market Analysis
Chapter 6 East Asia Injection Pen Market Analysis
Chapter 7 Europe Injection Pen Market Analysis
Chapter 8 South Asia Injection Pen Market Analysis
Chapter 9 Southeast Asia Injection Pen Market Analysis
Chapter 10 Middle East Injection Pen Market Analysis
Chapter 11 Africa Injection Pen Market Analysis
Chapter 12 Oceania Injection Pen Market Analysis
Chapter 13 South America Injection Pen Market Analysis
Chapter 14 Company Profiles and Key Figures in Injection Pen Business
Chapter 15 Global Injection Pen Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027